Your session is about to expire
← Back to Search
Coin2Dose for Type 1 Diabetes (Coin2Dose Trial)
Coin2Dose Trial Summary
This trial aims to see if incentives can help teens with diabetes use insulin better, using semi-automated tech.
Coin2Dose Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCoin2Dose Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Coin2Dose Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am a teenager who does not use an insulin pump.I have been diagnosed with type 1 diabetes for at least 6 months.Adolescents who have a daily BOLUS score below 2.5I use an insulin pump for my type 1 diabetes.I am allergic to the adhesive used for continuous glucose monitoring.I am a teenager with a long-term health condition like kidney disease.I am between 11 and 17 years old, or I am the parent/guardian of someone who is.I, or my parent, do not speak English.
- Group 1: Coin2Dose
- Group 2: Standard Care Control
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this research endeavor allow participants aged 18 and over?
"The criteria for being a part of this clinical trial states that the participant must be aged between 11 and 17."
Is it possible to register for this study at the current time?
"This clinical trial is still accepting participants. It was first listed on the 1st of January 2023 and last amended on 28th February 2023 per information provided by clinicaltrials.gov."
Am I eligible to participate in this scientific investigation?
"This trial is on the search for 150 juvenile individuals with type 1 diabetes, aged between 11 and 17 years. To be eligible to participate, adolescents must have a doctor-verified diagnosis of T1D lasting at least 6 months; they should use insulin pumps to manage their condition; and they need to demonstrate suboptimal daily BOLUS scores (a mean score lower than 2.5)."
How many participants are currently involved in this research endeavor?
"Affirmative. The info hosted on clinicaltrials.gov reveals that this research, which was initially advertised on January 1st 2023, is still actively recruiting participants. 150 people are required to be enrolled from 2 medical centres."
Share this study with friends
Copy Link
Messenger